Eltrombopag directly inhibits BAX and prevents cell death
Open Access
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-15
- https://doi.org/10.1038/s41467-021-21224-1
Abstract
The BCL-2 family protein BAX has essential activity in mitochondrial regulation of cell death. While BAX activity ensures tissue homeostasis, when dysregulated it contributes to aberrant cell death in several diseases. During cellular stress BAX is transformed from an inactive cytosolic conformation to a toxic mitochondrial oligomer. Although the BAX transformation process is not well understood, drugs that interfere with this process are useful research tools and potential therapeutics. Here, we show that Eltrombopag, an FDA-approved drug, is a direct inhibitor of BAX. Eltrombopag binds the BAX trigger site distinctly from BAX activators, preventing them from triggering BAX conformational transformation and simultaneously promoting stabilization of the inactive BAX structure. Accordingly, Eltrombopag is capable of inhibiting BAX-mediated apoptosis induced by cytotoxic stimuli. Our data demonstrate structure-function insights into a mechanism of BAX inhibition and reveal a mechanism for Eltrombopag that may expand its use in diseases of uncontrolled cell death.Funding Information
- Irma T. Hirschl Trust
This publication has 52 references indexed in Scilit:
- Structural mechanism of Bax inhibition by cytomegalovirus protein vMIAProceedings of the National Academy of Sciences of the United States of America, 2012
- Direct and selective small-molecule activation of proapoptotic BAXNature Chemical Biology, 2012
- Bcl-xL Retrotranslocates Bax from the Mitochondria into the CytosolCell, 2011
- BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death ProgramScience, 2010
- BH3-Triggered Structural Reorganization Drives the Activation of Proapoptotic BAXMolecular Cell, 2010
- Mitochondria and cell death: outer membrane permeabilization and beyondNature Reviews Molecular Cell Biology, 2010
- Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial ApoptosisMolecular Cell, 2009
- Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor AgonistThe International Journal of Cell Cloning, 2009
- BAX activation is initiated at a novel interaction siteNature, 2008
- Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene DosagePLoS Genetics, 2005